Showing 3461-3470 of 7016 results for "".
Looking Beyond LDL to Reduce Cardiovascular Events
https://reachmd.com/programs/lipid-luminations/looking-beyond-ldl-to-reduce-cardiovascular-events/3425/To effectively reduce one's cardiovascular risk, recent studies suggest it is necessary to treat multiple factors and not just the patient's LDL number. Dr. Brown discusses with host Dr. Larry Kaskel how studies that used a multi-factor approach, such as the Steno studies and the Champ study,LDL Apheresis
https://reachmd.com/programs/lipid-luminations/ldl-apheresis/3153/Dr. Larry Kaskel welcomes Dr. Donna Polk to Lipid Luminations. Dr. Polk is Director of Preventive Cardiology at Hartford Hospital in Hartford, Conneticut. Dr. Polk will discuss LDL Apheresis and the evidence supporting its use, what the procedure entails as well as who is eligible and where it is peResults of ADVANCE Diabetes Trial
https://reachmd.com/programs/lipid-luminations/results-of-advance-diabetes-trial/3822/The ADVANCE Study involved 11,140 high-risk patients with type 2 diabetes. Join host Dr. Larry Kaskel when guest Dr. Eliot Brinton explains the findings from the largest-ever study of treatments for diabetes, which provided no evidence of an increased risk of death among patients receiving aggManagement Issues in Familial Hypercholesterolemia
https://reachmd.com/programs/lipid-luminations/management-issues-in-familial-hypercholesterolemia/6480/Host Dr. Alan Brown discusses management issues and practical advice with certified registered nurse practitioner and clinical lipid specialist Joyce Ross, who says that familial hypercholesterolemia (FH) is the most common genetic disorder, and many who have it are totally unaware of their conditiPediatric Heart Disease: The Need for More Rigorous Clinical Evidence
https://reachmd.com/programs/heart-matters/pediatric-heart-disease-the-need-for-more-rigorous-clinical-evidence/4921/Although congenital heart disease is one of the most common birth defects, its complexity has made the accumulation of an evidence base a challenge. The IMPACT registry, which stands for improving pediatric and adult congenital treatments, has been created to fill this information gap, and it is hopThe Rapid Evolution of Ventricular Assist Devices
https://reachmd.com/programs/heart-matters/the-rapid-evolution-of-ventricular-assist-devices/5261/Options for patients with advanced heart failure used to be limited to heart transplantation, but ventricular assist devices have rapidly evolved into viable treatment options for these patients. How is the newest generation of continuous-flow devices impacting the way we care for patients with advaMetabolic Syndrome in Children and Adolescents
https://reachmd.com/programs/lipid-luminations/metabolic-syndrome-in-children-and-adolescents/3324/Dr. Larry Kaskel welcomes Dr. Catherine McNeal to Lipid Luminations. Dr. McNeal is an Associate Professor of Pediatrics and Associate Professor of Internal Medicine at The Texas A&M Health Science Center, College Station, Texas. Dr. McNeal will discuss the features of metabolic syndrome in childSERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
https://reachmd.com/programs/cme/serena-6-acting-on-esr1-mutations-in-advanced-breast-cancer/57229/Watch our experts review key ASCO 2026 data on oral SERD therapies in breast cancer and discuss the potential impact on treatment sequencing and patient care.Predicting Breast Cancer Metastasis with Proteomics
https://reachmd.com/programs/project-oncology/predicting-breast-cancer-metastasis-with-proteomics/49189/Molecular Signals and Early Detection in Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/molecular-signals-and-early-detection-in-psoriatic-arthritis/51048/